{
    "eid": "2-s2.0-85101388455",
    "title": "The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Wichai Termrungruanglert",
        "Nipon Khemapech",
        "Apichai Vasuratna",
        "Piyalamporn Havanond",
        "Preyanuch Deebukkham",
        "Amit Sharad Kulkarni",
        "Andrew Pavelyev"
    ],
    "citedby-count": 5,
    "ref-count": 30,
    "ref-list": [
        "Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine",
        "HPV vaccine cross-protection: Highlights on additional clinical benefit",
        "ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre)",
        "Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand",
        "Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries",
        "High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up",
        "Model for assessing human papillomavirus vaccination strategies",
        "Impact of vaccinating boys and men against HPV in the United States",
        "Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model",
        "Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis",
        "Cost-effectiveness of a potential vaccine for human papillomavirus",
        "The Evaluation of Outcomes and Determinants of Cervial Cancer Screening Programme Using Pap Smear and Visual Inspection with Acetic Acid in Thailand during 2005\u20132009",
        "Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe",
        "Thailand Country Brief (August 2017)",
        "Parents\u2019 preferences and willingness-to-pay for human papilloma virus vaccines in Thailand",
        "Handling time in economic evaluation studies",
        "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008",
        "Knowledge, acceptance, and willingness to pay for human papilloma virus (HPV) vaccination among female parents in Thailand",
        "Vaccine Prices: A Systematic Review of Literature",
        "Vaccine pricing: how can we get it right?",
        "Cost-effectiveness thresholds: pros and cons",
        "The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rahway",
            "@id": "60007995",
            "affilname": "Merck &amp; Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "107183007",
            "affilname": "MSD (Thailand) Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107183007",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}